619 related articles for article (PubMed ID: 15657662)
1. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of in vivo gene delivery by restriction enzyme PCR generated polymorphism.
Fichera A; Guo Y; Romero L; Michelassi F; Arenas RB
J Surg Res; 1997 Apr; 69(1):188-92. PubMed ID: 9202668
[TBL] [Abstract][Full Text] [Related]
3. Apc mice: models, modifiers and mutants.
McCart AE; Vickaryous NK; Silver A
Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487
[TBL] [Abstract][Full Text] [Related]
4. Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposis.
De Rosa M; Galatola M; Borriello S; Duraturo F; Masone S; Izzo P
Dis Colon Rectum; 2009 Feb; 52(2):268-74. PubMed ID: 19279422
[TBL] [Abstract][Full Text] [Related]
5. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.
Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A
Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel duplication in the APC gene using multiple ligation probe amplification in a patient with familial adenomatous polyposis.
Pedace L; Majore S; Megiorni F; Binni F; De Bernardo C; Antigoni I; Preziosi N; Mazzilli MC; Grammatico P
Cancer Genet Cytogenet; 2008 Apr; 182(2):130-5. PubMed ID: 18406876
[TBL] [Abstract][Full Text] [Related]
8. Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis.
Bright-Thomas RM; Agrawal A; Hargest R
Br J Surg; 2002 Dec; 89(12):1563-9. PubMed ID: 12445067
[TBL] [Abstract][Full Text] [Related]
9. Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis.
Yang K; Edelmann W; Fan K; Lau K; Leung D; Newmark H; Kucherlapati R; Lipkin M
Cancer Res; 1998 Dec; 58(24):5713-7. PubMed ID: 9865728
[TBL] [Abstract][Full Text] [Related]
10. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
Watson SA; Smith AM
Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
[TBL] [Abstract][Full Text] [Related]
11. Mutational screening of the APC gene in Chilean families with familial adenomatous polyposis: nine novel truncating mutations.
De la Fuente MK; Alvarez KP; Letelier AJ; Bellolio F; Acuña ML; León FS; Pinto E; Carvallo P; López-Köstner F
Dis Colon Rectum; 2007 Dec; 50(12):2142-8. PubMed ID: 17963004
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
[TBL] [Abstract][Full Text] [Related]
13. APC in the regulation of intestinal crypt fission.
Wasan HS; Park HS; Liu KC; Mandir NK; Winnett A; Sasieni P; Bodmer WF; Goodlad RA; Wright NA
J Pathol; 1998 Jul; 185(3):246-55. PubMed ID: 9771477
[TBL] [Abstract][Full Text] [Related]
14. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
[TBL] [Abstract][Full Text] [Related]
15. Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis.
Uckun FM; Erbeck D; Qazi S; Venkatachalam T; Tibbles HE; Vassilev A
Arzneimittelforschung; 2007; 57(6):320-9. PubMed ID: 17688077
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of both APC alleles in human and mouse tumors.
Levy DB; Smith KJ; Beazer-Barclay Y; Hamilton SR; Vogelstein B; Kinzler KW
Cancer Res; 1994 Nov; 54(22):5953-8. PubMed ID: 7954428
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of hyperlipidemia in increasing risk of colorectal tumor development in human familial adenomatous polyposis.
Mutoh M; Akasu T; Takahashi M; Niho N; Yoshida T; Sugimura T; Wakabayashi K
Jpn J Clin Oncol; 2006 Mar; 36(3):166-71. PubMed ID: 16478792
[TBL] [Abstract][Full Text] [Related]
18. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
19. Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis.
Valanzano R; Ficari F; Curia MC; Aceto G; Veschi S; Cama A; Battista P; Tonelli F
J Surg Oncol; 2007 Jan; 95(1):28-33. PubMed ID: 17192888
[TBL] [Abstract][Full Text] [Related]
20. Detection of APC gene deletion by double competitive polymerase chain reaction in patients with familial adenomatous polyposis.
Takahashi M; Kikuchi M; Ohkura N; Yaguchi H; Nagamura Y; Ohnami S; Ushiama M; Yoshida T; Sugano K; Iwama T; Kosugi S; Tsukada T
Int J Oncol; 2006 Aug; 29(2):413-21. PubMed ID: 16820884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
